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Creating a database of internet-based clinical
trials to support a public-led research
programme: A descriptive analysis
Anne Brice1, Amy Price1 and Amanda Burls2
Abstract
Background: Online trials are rapidly growing in number, offering potential benefits but also methodological, ethical and
social challenges. The International Network for Knowledge on Well-being (ThinkWellTM) aims to increase public and patient
participation in the prioritisation, design and conduct of research through the use of technologies.
Objective: We aim to provide a baseline understanding of the online trial environment, determining how many trials have
used internet-based technologies; how they have been used; and how use has developed over time.
Methods: We searched a range of bibliographic databases to March 2015, with no date limits, supplemented by citation
searching and references provided by experts in the field. Results were screened against inclusion and exclusion criteria,
and included studies mapped against a number of key dimensions, with key themes developed iteratively throughout the
process.
Results: We identified 1992 internet-based trials to March 2015. The number of reported studies increased substantially over
the study timeframe. The largest number of trials were conducted in the USA (49.7%), followed by The Netherlands (10.2%);
Australia (8.5%); the United Kingdom (5.8%); Sweden (4.6%); Canada (4%); and Germany (2.6%). South Korea (1.5%) has
the highest number of reported trials for other continents. There is a predominance of interventions addressing core public
health challenges including obesity (8.6%), smoking cessation (5.9%), alcohol abuse (7.7%) and physical activity (10.2%); in
mental health issues such as depression (10.9%) and anxiety (5.6%); and conditions where self-management (16.6%) or
monitoring (8.1%) is a major feature of care.
Conclusions: The results confirm an increase in the use of the internet in trials. Key themes have emerged from the analysis
and further research will be undertaken in order to investigate how the data can be used to improve trial design and
recruitment, and to build an open access resource to support the public-led research agenda.
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Introduction
Online clinical trials are rapidly growing in number.
This novel method for assessing the eﬀectiveness of
health interventions oﬀers tantalising potential beneﬁts
to researchers, patients and society, such as: reducing
the cost of studies; reducing the marginal cost of
recruiting additional participants, enabling larger
sample sizes and reducing random error; improving
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the representativeness of trials by enabling the involve-
ment of participants who tend to be neglected by cur-
rent research methods; improving recruitment to trials;
improving stakeholder involvement in trials; cheaper
treatments; permitting easier long-term follow-up of
participants; allowing novel questions to be addressed
that would not have been logistically possible to test in
traditional trials; and improved dissemination of
results. However, the online method also brings poten-
tial threats such as: the ease of setting up trials leading
to poor quality assurance; ease of recruitment leading
to large attrition rates and uninterpretable results; con-
tamination between arms due to social media or com-
munication between participants; the technological
challenges of doing research online leading to failed
trials; and exposure to hacking and potential breaches
of participant conﬁdentiality. It is important, therefore,
to evaluate this new technology to identify the actual
advantages and disadvantages of online clinical trials in
practice and to learn what factors can help maximise
beneﬁts and minimise risks.
ThinkWell
The International Network for Knowledge on Well-
being (ThinkWellTM)1 is a not-for-proﬁt organisation
set up by a group of consumers, researchers, health
service users and clinicians in 2006 with the mission
of using modern communication technologies to
enable the public and patients (a) to make health deci-
sions informed by the best available research evidence
and (b) to participate in health research on the issues
that aﬀect the day-to-day decisions of individuals,
involving the public in the prioritisation, design and
conduct of research. ThinkWell’s focus is on interven-
tions that people can choose to do for themselves, with-
out the involvement of a health care professional (such
as exclusion diets, online psychological therapies, life-
style choices, dietary supplements, etc.), and the organ-
isation is committed to an evidence-based approach
and stakeholder partnership throughout the research
process. The type of intervention ThinkWell is inter-
ested in (self-management) and the fact that all research
is designed and undertaken in partnership with the
public and patients means that online trials are a par-
ticularly appropriate methodology to address proven
uncertainties in this area. Therefore, it was important
for ThinkWell to learn from best practice in online
health trials regarding how to achieve meaningful
stakeholder collaboration to inform the methodo-
logical, safety, and ethical considerations speciﬁc to
the online environment. However, when ThinkWell
started work in this area there was little published evi-
dence about these issues. We decided to begin by look-
ing at existing online trials to learn about their
advantages and disadvantages; how stakeholders had
been involved; and identify good and bad practice in
conduct and reporting. A ﬁrst step was to systematic-
ally identify as many relevant online clinical trials as
eﬃciently as we could. This led to the creation of the
Online Randomised Controlled Trials of Health
Information Database (ORCHID). This paper
describes the rationale and methods of creating
ORCHID.
Rationale for public-led trials
Why involve the public and patients as partners in health
research? Measures to improve the health of citizens
by enabling them to make better-informed decisions
about their health and well-being have been supported
by national public health initiatives, media campaigns,
the development of patient education resources, and
tools to support shared decision making. An increase
in the use of internet and mobile technologies as a chan-
nel for health-related information and advice has led to
the development of computer-supported decision
aids24 and other self-management initiatives,5 in
tandem with the informal explosion of social media
applications,6 through forums and discussion groups,7
and communication activities designed to promote
behaviour change.8 Pew internet research states that
35% of adults have searched online to ﬁnd health infor-
mation,9 and in the UK government policies to tackle
issues such as smoking cessation and obesity, self-man-
agement of long-term conditions, and improvements in
mental health have been implemented through national
digital initiatives such as Change4Life10 and NHS
Choices.11
Internet technologies may provide an eﬃcient
and cost-eﬀective mechanism for the delivery of good-
quality health information, public health-focused inter-
ventions, and health and social care transactions. The
rapid rise in the use of smart phones, tablets and an
increase in the accessibility of mobile internet technol-
ogies has led to the promotion of a ‘digital ﬁrst’ strategy
for the Department of Health in England,12,13 which
has the stated aim of making all public-facing transac-
tions in health and social care digital by default.
However, there are concerns about a lack of research
into the impact of digital technologies in terms of
harms;14,15 on issues relating to digital skills;16 self-
diagnosis;17 and on health inequalities.1820 Mobile
technologies may provide an opportunity to support
community engagement,21 and although systematic
reviews report that community engagement initiatives
can impact positively on policy and practice, on health,
and on public health outcomes, there is a lack of strong
evidence on whether there is a beneﬁcial eﬀect on health
inequalities, comparative eﬀectiveness between models,
2 DIGITAL HEALTH
or on cost-eﬀectiveness.22 More high-quality syntheses
or studies are needed to inform reliable policy and prac-
tice about whether the increasing use of internet-based
technologies has the potential to improve health equity.
In addition to the increased awareness of the need to
promote better-informed and shared decision making,
there has also been an acknowledgement of the need for
a corresponding increase in patient and public involve-
ment (PPI) in policy making, planning and service
delivery,2326 health and social care guidance,27 patient
safety,28 and importantly, in the research process
itself.29 Lack of meaningful stakeholder involvement
has the potential to add to the waste identiﬁed in the
research process by,30 and represents a lost opportunity
to harness new technologies for, socially led research.31
It has been suggested that without full involvement
at all stages of the research process, much of the
research activity that is conducted will not answer the
questions that are most important to patients and
the public,3235 and that a more participative research
process will lead to better quality and more relevant
research output. A range of policies and programmes
have been implemented with the aim of improving PPI
in health-related research, although there are concerns
that this has been largely driven by a researcher-led
agenda.36 Chalmers37 suggests that most health-related
research is commissioned by policy makers and
designed mainly by researchers, and often only involves
patients and future participants after its initiation.
Failure to involve potential participants in the priori-
tisation and design of research may partially explain
why trials fail to recruit suﬃcient numbers or encounter
a lack of cooperation from those who enrol patients at
the point of care. The use of social networking sites to
increase public involvement in health research and
practice has been increasing, and guidance has been
published to aid researchers;38 however, further explor-
ation of the full potential is required. Studies are often
observational in design and lack the capacity to fully
explore the interactional potential of the media.
Randomised controlled clinical trials are the current
methodology of choice for testing the eﬀectiveness of
interventions because they minimise potential biases
(for example, pre-existing diﬀerences in the groups
being compared). However, there are known limita-
tions and problems associated with their conduct, par-
ticularly in the area of public health and well-being.
Problems include failures to recruit suﬃcient sample
sizes, the costs associated with running large trials,
problems in follow-up, and relevance.39,40 This may
impact on the ability to provide answers to the most
important questions for patients, the public and clin-
icians, but also on the successful involvement of
patients and the public in trial design and conduct,41
with a lack of engagement contributing to concerns
about poor reporting, publication bias and the suppres-
sion of information about adverse events and harms.42
This lack of transparency undermines the conﬁdence
placed in reported ﬁndings4345 as well as providing
another barrier to increased public involvement.
These concerns have led to a number of initiatives to
improve the quality of research evidence through syn-
thesis in systematic reviews, better reporting stand-
ards46 and a commitment to make patients aware of
research in the NHS Constitution in England,47
although the failure to register clinical trials remains a
matter of serious concern.48
Consideration of these issues has led to speciﬁc ini-
tiatives that aim to harness the development of new
technologies as a mechanism to both improve the
useful outcomes of clinical research, built on the prin-
ciples of involvement and through the development of
public-led research.
While a growing interest in the use of internet tech-
nologies in general within clinical trials has been iden-
tiﬁed from an early stage in the development of the
medium,49,50 studies using internet technologies vary
in the aspect and degree to which these tools are
employed at diﬀerent stages of the trial process, includ-
ing recruitment, gaining consent, data collection,
and the dissemination of results. As the adoption of
internet-based technologies in clinical trials has
increased rapidly, it has led to unstructured approaches
to reporting and indexing, which in turn leads to prob-
lems in the retrieval of relevant studies, and in the
assessment of quality and reliability. Murray51 identi-
ﬁed a set of issues concerning the use of the internet in
clinical trials, and has suggested that online trials share
common issues with traditional trials, such as recruit-
ment and retention, randomisation, data quality and
ﬁdelity, but face additional challenges related to their
technological characteristics, including spamming, data
theft, and ‘cybersquatting’.
In a rapidly changing technical environment, the
problems associated with the ability to be able to rep-
licate interventions in reports of clinical trials52 may be
an even greater challenge.53 Internet technologies have
the potential to be used in all stages of trial conduct;
however, scoping searches reveal that the most
common application in the reports of clinical trials is
in the delivery of the intervention or comparison, such
as in studies investigating substance misuse;54,55 smok-
ing cessation;56 weight loss;57 and in the use of cognitive
behavioural therapies.58 The growth of this type of trial
is reﬂected through an increasing number of published
systematic reviews of these types of studies,5962 and
also in the appearance of national guidance.63
However, there are currently no agreed standards for
the description or indexing of these concepts in individ-
ual studies, or in systematic reviews.
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Given the lack of a robust evidence base, it was
decided that a more systematic approach to the iden-
tiﬁcation of uncertainties in relation to internet-based
clinical trials would be useful for the emerging
ThinkWell programme and for other researchers in
the ﬁeld of health research. UK DUETS64,65 was
established in 2007 in order to identify, collate and
publish uncertainties about the eﬀects of treatments.
Information in UK DUETs not only helps health pro-
fessionals identify treatment uncertainties quickly, but
can also help those responsible for promoting and
supporting research focus on important gaps in know-
ledge and the unmet information needs of patients and
clinicians. A project to adapt the UK DUETs meth-
odology to investigate the most important questions in
relation to the use of internet-based technologies in
health and well-being research was piloted, and ana-
lysis of the initial results showed that a number of
important questions could beneﬁt from further
research.66 These included areas such as data security,
data collection, self-report issues, and technological
solutions, but also raised broader questions concern-
ing ethical, methodological and qualitative perspec-
tives. It was unclear how many clinical trials had
already been conducted using internet-based
approaches, and to what extent they had been used
in speciﬁc stages or elements of the trial process. We
set out to consider the epidemiology of internet-based
clinical trials, with the aim of establishing some core
baselines and a better understanding of current activ-
ities, through a project to identify, classify, record and
analyse reports of trials.
The ORCHID project
The ORCHID project was proposed to create a reposi-
tory of internet-based clinical trials in health and well-
being topics, to provide a baseline understanding of the
nature of the internet-based clinical trial environment.
We propose to use ORCHID to mine for trends in trial
topics and types of interventions, to identify methods
used in online trials, to explore how and when PPI is
used, as well as any other emerging trends in the devel-
opment of online trials.
The initial project aimed to address the following
questions:
. How many randomised controlled trials have used
internet-based technologies as part of their trial
processes?
. In what stages of the trial process have internet-
based technologies been used and how might these
be characterised?
. How has the use of internet-based technologies in
randomised controlled trials developed over time?
The mapping process aimed to establish the relevant
concepts and the size of the literature, and will feed into
the process of establishing priorities for research in this
area alongside further development of the ThinkWell
uncertainties harvesting project.
Methods
Definitions and scope
One of the major impediments in identifying internet-
based clinical trials is related to the lack of a consistent
taxonomy, and the wide range of terms used in both the
reporting of the trial and the quality of indexing of
trials in bibliographical databases. For the purposes
of this project, the following deﬁnitions were used for
key concepts.
Internet-based. The ‘internet’ concept is deﬁned in the
Oxford English Dictionary as ‘‘a global computer net-
work providing a variety of information and commu-
nication facilities, consisting of interconnected
networks using standardized communication proto-
cols’’. For the purposes of this research, the term
‘internet-based’ was used predominantly to refer to
applications which use the world wide web as a primary
means of communication or data entry, including the
use of mobile technologies where these are used in com-
bination with the internet.
Randomised controlled trials. The ﬁrst phase of the data-
base development focused on identifying a core set of
reports of internet-based randomised controlled trials.
To be considered for inclusion in the initial develop-
ment phase, reports of studies needed to include refer-
ence to a randomisation process in the abstract, to be
indexed with a relevant publication type, or to have
‘randomised controlled trial’ included in a declarative
title. No assessment of trial quality was undertaken at
this stage.
Health and well-being. The potential range and scope of
this topic is extremely large, and the concept of ‘health’
is subject to a range of diﬀerent interpretations and
deﬁnitions. The focus for the initial database develop-
ment was therefore limited to reports of trials relating
to interventions in diagnosable illnesses or disorders,
including non-communicable diseases and conditions.
ICD10 categories were used to provide additional guid-
ance for the inclusion or exclusion of borderline topics,
for example in the area of addiction. For the term ‘well-
being’, there is even less consensus concerning how this
should be deﬁned, particularly in the boundaries
between the concepts of ‘mental health’ and ‘well-
being’. The recent government strategy for mental
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health No health without mental health; a cross-
government mental health outcomes strategy for people
of all ages, 201167 provides the following deﬁnitions:
Good or positive mental health is more than the
absence or management of mental health problems; it
is the foundations for well-being and eﬀective function-
ing both for individuals and for their communities.
Well-being is a positive state of mind and body, feeling
safe and able to cope, with a sense of connection with
people, communities and the wider environment
Factors aﬀecting adult health, such as sexual and repro-
ductive health and drug misuse, were included, but only
where there was a deﬁned health care, or public health,
intervention. In order to manage the scope of the initial
phase of development, other social determining factors
such as housing, transport and planning, or broader
environmental health; issues around ageing; domestic
violence; or accidental injury were excluded.
Trial participants. Trials would be included if the partici-
pants were patients or members of the public. Trials
dealing exclusively with health care professionals
would be identiﬁed but not included for analysis at
this stage.
Identifying and selecting studies
Search methods. A broad and comprehensive search
strategy was developed, and a wide range of sources
used in order to retrieve relevant studies. The following
sources were searched to identify relevant studies:
MEDLINE; EMBASE; PsycINFO; CINAHL; The
Cochrane Controlled Trials Register (CCTR);
Physiotherapy Evidence Database (PEDro); OT
Seeker; ERIC; and LILACS. The search strategies are
listed in Appendix 1.
Given the wide range of databases searched, their
diﬀerent functionalities and tools, the search strategy
was adapted for each source. For health-related data-
bases the ‘internet’ concepts were combined with a
methodological ﬁlter for randomised controlled trials.
For non-health-related databases the ‘internet’ con-
cepts were combined with health or well-being terms,
as well as any relevant randomised controlled trial con-
cepts or methodological ﬁlters if available.
It was determined that although the preference was
for conducting a comprehensive search in a wide range
of sources, i.e. not just MEDLINE and EMBASE, in
some smaller databases it would be more pragmatic
and cost eﬀective to use a single term or less sensitive
approach, if a more precise or tested ﬁlter were not
available. This would be supplemented by hand search-
ing of journals, personal contacts, and citation and
pearl searching of key papers. No speciﬁc date limits
were applied to the search, due to a lack of clarity as to
when trials ﬁrst started to use the internet as a tool, and
also due to the variable rate of development of diﬀerent
internet technologies.
Health and well-being research and randomised con-
trolled trials are international in scope and relevance,
and therefore no language limits were applied.
However, reports of research in languages other than
English were only included if an English abstract was
available.
Search terms were derived from MeSH, EMBASE,
and other relevant taxonomies; from core articles iden-
tiﬁed from scoping searches; and by experts in the ﬁeld.
A process of text word analysis was undertaken, and
the identiﬁed relevant thesaurus and free-text terms,
and combinations of terms, tested where possible. As
previously reported, there is a very wide variation both
in terminology, deﬁnition and application of internet-
based technologies within the research environment,
resulting in a complex set of activities which are not
well controlled in terms of taxonomy or indexing.
Internet-based technologies. The term ‘internet’ itself rep-
resents a poorly controlled concept, and as use of the
technology itself has increased over time, the term has
become almost ubiquitously used in study reports. For
example, the terms ‘‘web’’ and ‘‘online’’ are frequently
retrieved as text words due to statements such as ‘‘we
searched the web for xx’’. Some of the terms that were
tested retrieved very large numbers of irrelevant results,
for example, using ‘‘e-’’ as a preﬁx to terms such as ‘‘e-
research’’ retrieves examples such as ‘‘Vitamin E’’.
Where possible, controlled vocabularies were used; for
instance, the MeSH term ‘‘internet’’ was created in
1999, with the previous indexing term of ‘‘computer
communication networks’’ becoming a broader term.
All subheadings of ‘‘internet/’’ were included to
increase sensitivity.
Randomised controlled trials. Relevant search ﬁlters for
randomised controlled trials were identiﬁed for
MEDLINE, EMBASE, PsycINFO and CINAHL. In
order to ensure that a systematic approach was taken
to the choice of ﬁlter, a literature search was under-
taken to identify what was known about speciﬁc ﬁlter
characteristics and performance.6871 Poor and incon-
sistent indexing within and between databases made it
diﬃcult to compare the performance of speciﬁc terms
and ﬁlters. This meant that the choice of methodo-
logical ﬁlter to identify reports of randomised con-
trolled trials would have a high impact on the number
of retrieved records. Test searches were run to estimate
likely outcomes which resulted in poor performance in
terms of the precision of the tested ﬁlters, and the very
Brice et al. 5
broad and sensitive nature of the other concept terms of
the search led to the potential retrieval of a very large
number of results. Therefore although the preference
was to use a highly sensitive search strategy in order
to increase sensitivity, a pragmatic approach had to be
taken to achieve maximum balance between sensitivity
and precision.
The initial database searches were run in January
2011, with further update searches completed in
September 2013, and January 2015. The combined
searches identiﬁed 21,813 results, which were down-
loaded to EndNote, and then transferred to the
SENTE software package for screening and indexing.
The results were then screened using the inclusion and
exclusion criteria. Results were initially ordered by year
of publication, to identify how the number had
increased over time.
Selection of studies
Stages of the trial process. The database was developed to
identify at which stage of the trial process internet tech-
nologies have been used. This would include use of the
internet to gain informed consent, self-enrolment, the
delivery of the intervention, data collection and ana-
lysis, and outcome measurement. Given that the use
of internet tools for trial registration, randomisation,
publicity and promotion, or dissemination has
become standard practice in most clinical trials, reports
of studies where the only reference to the use of the
internet is related to these concepts were excluded.
Iterative classification and labelling. The retrieved studies
were then indexed to record their core characteristics,
including the country the trial took place in, the condi-
tions being investigated, and the interventions being
tested. Initially studies were indexed using the terms
applied by the source database, such as MeSH. Given
that the source databases use a range of diﬀerent con-
trolled vocabularies, and the lack of consistency of
indexing within databases, a pragmatic, hybrid system
was developed. This entailed a two-stage process, where
the condition and intervention indexing terms were
extracted from the relevant ﬁeld in each study report,
using the classiﬁcation label provided by the source
database. This was then mapped against the existing
set of codes, and an iterative process. If a relevant
code was already in the structure, this was applied. If
no relevant code was available, a new code was created
using the terminology from the study report in ques-
tion. When the indexing was completed, the results
were scanned for consistency and re-labelled where
appropriate. As it was envisaged that detailed analysis
within speciﬁc condition or intervention areas would be
undertaken by topic experts as part of secondary pro-
jects, no further work on the classiﬁcation was under-
taken at this stage.
Results
The current number of identiﬁed internet-based rando-
mised controlled trials in the database as of January
2015 is 1992.
Identified studies
Date of publication. The number of reports of internet-
based randomised controlled trials retrieved and added
to the database by year of publication increased as
expected over time, with the majority published
between 2007 and 2015 (Figure 1).
Geography. The largest number of trials reported as
using internet technologies were conducted in the
USA (49.7%), followed by The Netherlands (10.2%),
Australia (8.5%), the United Kingdom (5.8%), Sweden
(4.6%), Canada (4%), and Germany (2.6%). South
Korea (1.5%) has the highest number of reported
trials for other continents.
Topic. The topics most often studied were those report-
ing interventions relating to non-communicable condi-
tions such as obesity, smoking and substance abuse,
depression, anxiety and phobias. The second largest
group contained conditions where self-management is
already a major feature of clinical care, for example in
diabetes and cardiovascular conditions. The fastest
Textbox 1. Inclusion and exclusion criteria.
All studies that meet the following criteria were included:
 randomised controlled trials using internet-based technologies in
the trial process
 studies using mobile technologies where there is also internet-
based activity
 studies investigating health research, public health research topics
and settings
 studies that include educational or behavioural interventions of
health and well-being topics
 Studies involving patients or members of the public
The following studies were excluded:
 Studies using mobile telecommunications technologies exclusively,
with no internet-based content
 Studies investigating interventions in social care or educational
settings, where the main topic of investigation is not health related,
or where clinical diagnoses are not included in ICD10
 Studies where participants were health professionals or students
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growing ﬁelds of interest in the period between 2010
and 2014 were in treatments for depressive disorders
and obesity (Table 1).
Intervention. The highest numbers of concepts indexed
for study interventions related closely to the nature of
the conditions, as reported previously; for example,
behaviour change therapies, such as cognitive behav-
ioural therapy for anxiety and depression; smoking ces-
sation interventions, and interventions to increase
physical activity (Table 1). The ranked concepts reﬂect
the most speciﬁc terms as indexed by the source data-
base, and are therefore an indication of the intervention
and not grouped by permuted index (Table 2).
Discussion
A number of key themes have emerged from the initial
analysis of the study reports that have been included in
ORCHID. These themes reﬂect the rapid growth of the
use of internet technologies in health and well-being
research, but also raise issues which require further
investigation.
Location of trials
It is clear from the analysis of the trial location map-
ping that a high percentage of internet-based trials were
conducted in a small number of countries. This may
reﬂect existing publication bias in the scientiﬁc litera-
ture, and in the selection of journals indexed in biblio-
graphic databases, previously found in studies of
country and language of publication, such as in
MEDLINE, where in a 60-year period the USA
Table 1. Highest ranked topics or condition concepts.
No of trials % of included trials
Topic
depression 218 10.9
obesity 171 8.6
cancer 162 8.1
alcohol abuse 154 7.7
diabetes 133 6.7
cardiovascular diseases 131 6.6
anxiety 111 5.6
stress 79 4
phobias 49 2.5
Figure 1. Cumulative growth in internet-based RCTs.
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(22.2%) and United Kingdom (12.5%) produced most
publications reporting randomised controlled trials.72
Of 468,191 journal articles added to MEDLINE in
2000, 67.9% were initiated in the ‘Anglo’ countries.73
This is conﬁrmed in some respects from the ORCHID
data, although we have observed a trend where a small
number of key centres of excellence have developed,
with expertise in the conduct of speciﬁc types of
internet-based clinical trials. This may reﬂect the
interest and publications of one research group or
researcher, who publish multiple studies on either
the same set of trials or sequences of trials on similar
interventions, and may skew the position of that coun-
try in the overall table.
Expertise in the conduct and evaluation of internet-
based clinical trials has developed in small pockets, and
this learning could be shared to beneﬁt others in terms
of the methodological and economic advantages.
Improvements in the ability to recruit and retain trial
participants could help in a number of environments,
including large-scale public health trials, and in particu-
lar in the availability and conduct of research in under-
developed countries. At this moment in time research
using these technologies tends to favour the diseases
and conditions of high-income countries.
Type of topic and intervention
There is clearly a predominance of results in two main
topic areas. These are those relating to modiﬁable risk
factors for preventable causes of death and illness that
impact on public health priorities, such as tobacco,
obesity and lack of physical activity, and alcohol and
substance abuse; and mental health concerns such as
depressive disorders, anxiety and phobias.
It is not surprising, then, that the most common
interventions in the database are those related to exist-
ing treatment options for these conditions, and where
the delivery of the intervention transfers more easily to
an internet-based mode of delivery, such as those for
weight loss and smoking cessation programmes, talking
therapies and physical activity interventions. It is not
known how much the nature of the technology may
pre-dispose to a particular choice of intervention.
To improve the relevance of treatment options being
tested, future research in partnership with patients and
the public could be based on uncertainties and the most
important questions for patients, carers and practi-
tioners. This could ensure that the technological
options under consideration are driven by research
need rather than by researcher preference. It is not
clear whether the predominant topic areas reﬂect the
most relevant use for internet-based technologies, or
whether those particular researchers bring their interest
in the technology to bear on their subject through a
preference or interest in that technology.
Stage of trial
The majority of internet applications represented in
ORCHID are used in the delivery of the intervention.
Some 669 studies were indexed as reporting use of
the internet for data collection, and 387 indexed as
self-reporting. A large number of the most popular
interventions use the internet to enable participants to
self-report data, but there is not yet a body of trials
using this in non-behavioural trials. Sixty-four studies
were indexed as reporting use of the internet for data
analysis or follow-up. Very few of the studies identiﬁed
use internet technologies in other stages of the trial
process. Some 176 studies were retrieved that reported
on the methodological issues related to internet-based
trials. These were not entered into the database, but
Table 2. Highest ranked intervention concepts as indexed.
No of trials
% of included
trials
Intervention
Psychotherapy 674 33.8
Behaviour change 613 30.8
Education 398 20
Cognitive behavioural therapy 376 18.9
Health promotion 335 16.8
Self-management 331 16.6
Communication 214 10.7
Physical activity 204 10.2
Health information/literacy 167 8.4
Monitoring 162 8.1
Social support 157 7.9
Feedback 156 7.8
Weight loss 155 7.8
Web-based care 135
Risk assessment 130
Smoking cessation 117
Counselling 109
Nutrition 105
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were incorporated into work to conduct a methodo-
logical systematic review. Further work will be under-
taken by ThinkWell researchers to investigate speciﬁc
internet applications within these trials, and to develop
more speciﬁc taxonomies.
Limitations
The large number of results from the US, UK and
Australia, and therefore the predominance in English-
speaking, high-income countries, may be due to publica-
tion bias in terms of reported studies, journal indexing
and choice of databases searched. The issue of resource
allocation must be considered as other countries may
experience bandwidth limitations, limited access to the
technology required for online trials or reduced access to
the internet or internet-wired devices. Other consider-
ations such as research capacity, governance, online
and data security, and technological capacity will also
need to be in place to fully exploit internet-based trial
potential. ThinkWell is actively seeking partnerships
with researchers in low-income countries in order to col-
laborate and promote knowledge transfer.
A major challenge of the project was to develop
and pilot a set of search terms, phrases, and combin-
ations in order to retrieve references to, or about,
internet-based clinical controlled trials. Indexing in
some non-medical databases is poor and uncontrolled,
leading to retrieval problems and the need for exces-
sive amounts of screening and ﬁltering due to poor
reporting of studies and abstracts. Although compre-
hensive search strategies and ﬁlters were developed as
part of this project, the changing nature of the termin-
ology, which is in line with the pace of socio-technical
change, requires an exponential list of free-text search
terms in the absence of recognised controlled vocabul-
aries and ontologies.
Given the need to retrieve as many relevant studies
as possible, the search strategy needed to be highly sen-
sitive, but when combined with the poorly controlled
terms for the ‘internet’ concept, this led to extremely
large numbers of results with very poor precision.
Because of this, the range and scope of databases
used was restricted, and made it diﬃcult to determine
the impact of not using validated ﬁlters.
A number of diﬀerent approaches to the description
of terms were identiﬁed, including the development of
taxonomies on behaviour change,74 regular updates
of MeSH,75 the work of individual review groups or
researchers, and organisations such as WHO76 and
the National Institute of Health and Care Excellence
(NICE).77 Work is underway to improve the reporting
of interventions,78 and this research on the identiﬁca-
tion of internet-based trials could feed into the better
co-ordination of approaches to taxonomies and
labelling. Standardisation in indexing methodology
could complement transparency in research and lead
to more eﬀective searching and reporting of internet-
based clinical trials research.
Definition of concept of ‘health and well-being’
Health and well-being is a very wide concept. Using the
ICD categories was a pragmatic way of limiting the
results, for instance in relation to the concept of addic-
tion, which was restricted to drug/alcohol but excluded
internet addiction, as the primary focus of the project
was on health care and public health settings. This may
have resulted in missed trials.
Indexing and coding
Similar limitations were experienced in the terms used
for coding and indexing included studies. A search of the
literature revealed a number of potential alternative sys-
tems for the coding of studies, particularly in the area of
behaviour change interventions. Grimshaw et al.79 draw
attention to four Cochrane Reviews that cover inter-
active health communication applications; interventions
to enhance medication adherence; contracts; and new
methods of communication. Within the original cited
reviews, speciﬁc elements of existing controlled terms,
consistent with MeSH and other major taxonomies,
are used in diﬀerent combinations, including social sup-
port, decision support, and behaviour change support.
Haynes et al.80 identify a range of interventions used
within trials for medication adherence, including
instruction, counselling, family interventions, mentor-
ing, etc. This approach, although ensuring consistency
with the original decisions made by indexers, does not
reﬂect consistency across all the studies, and therefore
the categories tabled may include a range of intervention
headings and classiﬁcations that are not comparable.
The mapping relied on the terms used by authors to
report their studies, and on the indexing terms chosen
by the host database. No quality appraisal of individual
studies was made, other than that of determining
whether the study was a randomised controlled trial
by looking for reports of randomisation.
Conclusions
There is clearly a need to develop communities of prac-
tice to share learning and expertise in internet-based clin-
ical trials, and to ensure that the public-led aspects
embedded in the nature of the technologies is harnessed.
This will be one of the major aims of the ThinkWell and
PLOT-IT initiatives. The original purpose for creating
ORCHID was as an internal resource for ThinkWell;
however, as interest from other researchers was high,
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we decided to continue to add results after the initial
searches in 2011 and to publish the details of
ORCHID’s methods and ﬁndings to date. Interest
from external research teams has led to collaboration
on other projects, including a text-mining project.
To increase public engagement and to inform future
internet-based clinical trials, the ThinkWell community
will embed participatory processes in the future develop-
ment of the database, the PLOT-IT platform81 and the
harvesting and prioritisation of research priorities. A
core group of citizens is being recruited to help plan this
process, and carry out a social network analysis. A two-
stage systematic review isbeingundertaken tomapwhat is
known about internet-based clinical trials, and to synthe-
sise speciﬁc aspects of the known uncertainties, including
questions about ethics, methodology, and qualitative per-
spectives.82 Qualitative work is also underway to explore
both researcher and public experience in internet-based
clinical trials, which will help to identify additional learn-
ing and support tools for all those involved in this area.
ORCHID has the potential to be a useful resource for
researchers to mine data from the included studies, and
will also be expanded to include a repository of what is
known about the conduct of internet-based trials. Future
development is planned to enable open access to this
resource, to support the development of a community of
practice which any researcher ormember of the public can
use. It is currently used as a resource to identify key terms
for search strategies, and to further determine trends in
this rapidly developing area. Regular updates are pro-
jected, and additional sources will be explored to increase
comprehensive coverage, and to enable ThinkWell to
expand the progression of public-led research.
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Appendix 1
Medline  Ovid Medline 1948  January Week 1 2011
Update 13/01/13
1. exp Computer Communication Networks/
2. (internet$ or web$ or online or on-line).mp.
[mp¼title, abstract, original title, name of sub-
stance word, subject heading word, keyword head-
ing word, protocol supplementary concept, rare
disease supplementary concept, unique identiﬁer]
3. 1 or 2
4. randomized controlled trial.pt.
5. controlled clinical trial.pt.
6. randomized.ab.
7. placebo.ab.
8. clinical trials as topic.sh.
9. randomly.ab.
10. trial.ti.
11. 4 or 5 or 6 or 7 or 8 or 9 or 10
12. exp animals/not humans.sh.
13. 11 not 12
14. 3 and 13
Embase: Ovid Embase 1980  2011 Week 02: 18/1/11
Update 13/01/13
1. (internet$ or online or on-line).mp. [mp¼title,
abstract, subject headings, heading word, drug
trade name, original title, device manufacturer,
drug manufacturer, device trade name, keyword]
2. random$.tw. or placebo$.mp. or double-
blind$.tw.
3. 1 and 2
PyscINFO: 1987 to January Week 1 2011
1. (internet$ or web$ or online or on-line).mp.
[mp¼title, abstract, heading word, table of con-
tents, key concepts, original title, tests & measures]
2. (random$ adj assigned).tw.
3. double-blind.tw.
4. control.tw.
5. 2 or 3 or 4
6. 1 and 5
Cinahl: EBSCO 01 Feb 2011
1. (MH ‘‘Internetþ’’)
2. web* OR internet* OR online
3. s1 OR s2
4. PT clinical trial
5. MH ‘‘Treatment Outcomesþ’’
6. TX randomized
7. s4 OR s5 OR s6
8. s3 AND s7
ERIC: ProQuest 03 Feb 2011
tbc
Pedro
1. Internet OR web OR online in Abstract or Title
AND Method: clinical trial
OT Seeker
1. internet OR web OR online AND Method:
Randomised Controlled Trial
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